Engineering Biology: The Next Frontier
from Azeem Azhar's Exponential View Hosted by EPIIPLUS 1 Ltd / Azeem Azhar
The increasing capabilities of computing have changed biology from a realm dominated by scientific discovery to one that intersects with engineering and innovation. Vijay Pande, a General Partner at Andreessen Horowitz, joins Azeem Azhar to discuss the emergence of this novel industry at the interface of technology and biology. They also discuss: The most promising technologies to combat Covid-19 that are being tested. Why next-gen biotech companies look increasingly like tech startups. Why our long-term health depends on regulators and society engaging with this tech. Further reading: “The Next Trillion Dollar Market” (Exponential View podcast, 2020) “Drug Discovery in the Age of Coronavirus” (Vijay Pande, 2020) @VijayPande @Azeem @exponentialview Exponential View newsletter SUPPORT US! If you love what we do, please take a moment to vote for us: British Podcast Awards, Listener’s Choice. About Exponential View: Welcome to Exponential View, where Azeem Azhar examines how exponential technologies such as AI are reshaping the future. Each week, Azeem shares his analysis or speaks with an expert guest to shed light on frontier shifts across technology, business and society. To keep up with the Exponential transition, subscribe to this channel or the newsletter: https://www.exponentialview.co/ To keep up with our AI economy research, subscribe to https://www.investmentbrief.ai/ Where to find me: Exponential View newsletter: https://www.exponentialview.co/ Website: https://www.azeemazhar.com/ LinkedIn: https://www.linkedin.com/in/azeem/ Twitter/X: https://x.com/azeem Production by EPIIPLUS1. Production and research: Baba Films, Marija Gavrilov.
Embed this episode
What this episode covers
Drug discovery, novel materials, and genetic engineering are some of the topics under the microscope in Azeem Azhar’s discussion with Andreessen Horowitz general partner Vijay Pande. They explore the extraordinary possibilities that are opening up at the intersection of biology, engineering, and innovation.
No transcript yet.